Liposem 2 MG (Saroglitazar Magnesium) Tablets
Introduction Liposem 2 mg (Saroglitazar Magnesium) Tablet is a pioneering dual peroxisome proliferator-activated receptor (PPAR) agonist designed to manage diabetic dyslipidemia and hypertriglyceridemia in patients with Type 2 diabetes mellitus inadequately controlled by statins. Manufactured by Everest Pharmaceuticals Ltd., a WHO-GMP-certified leader in metabolic disorder therapies, and supplied globally by Onco Solution, Liposem 2 mg (Saroglitazar Magnesium) Tablet addresses both lipid […]
Ventoxen 100 MG (Venetoclax) Tablets
Introduction to Ventoxen 100 MG: A New Horizon in Oncology Care Ventoxen 100 mg, a groundbreaking development by Everest Pharmaceutical Ltd., marks a pivotal advancement in the field of oncology, particularly for patients with hematologic malignancies. This innovative medication, centered around the active ingredient Venetoclax, emerges as a beacon of hope in cancer treatment. Supplier […]
Gilternib 40 MG (Gilteritinib) Tablets
Introduction: Gilternib 40 mg, infused with Selpercatinib and developed by Everest Pharmaceutical Ltd., heralds a significant milestone in precision oncology. This novel medication delivers targeted therapy to patients with specific genetic mutations, offering renewed hope and substantially improved outcomes for those battling advanced cancer forms. Description and Usage: Gilternib 40 mg incorporates Selpercatinib, a selective […]
Ivosenib 250 MG (Ivosidenib) Tablets
Introduction to Ivosenib 250 MG: Targeting IDH1 Mutations in Cancer Ivosenib 250 belongs to a class of medications known as IDH1 inhibitors. Mutations in the isocitrate dehydrogenase 1 (IDH1) gene are prevalent in various cancers, including acute myeloid leukemia (AML) and gliomas. These mutations trigger the production of oncometabolite 2-hydroxyglutarate (2-HG), fostering tumorigenesis and disease […]
Moboxen 40 MG (Mobocertinib) Capsules
Introduction to Moboxen 40 mg Moboxen 40 mg, crafted by Everest Pharmaceutical Ltd., represents a groundbreaking advancement in the field of precision oncology. Infused with the active ingredient Mobocertinib, this medication is specifically designed to target genetic mutations, providing new hope and significantly improved treatment outcomes for patients battling specific types of cancer. Description and […]
Selinex 20 MG (Selinexor) Tablets
Introduction: Selinex 20 mg, featuring Selinexor as its key component and crafted by Everest Pharmaceutical Ltd., emerges as a pivotal development in oncology. This medication embodies a new phase in cancer therapy, offering targeted treatment for patients with specific cancer types, fostering hope, and significantly improving their treatment journey. Description and Usage: Selinex 20 mg […]
Tivoxen 1.34 MG (Tivozanib) Capsule
Introduction to Tivoxen 1.34 mg Tivoxen 1.34 mg, featuring Tivozanib as its active ingredient and developed by Everest Pharmaceutical Ltd., represents a transformative breakthrough in the treatment of oncology. This medication delivers targeted therapy for patients with specific cancer types, ushering in renewed hope and significantly improved treatment outcomes. Description and Usage of Tivoxen Tivoxen […]
Trifluxen 15 MG +6.14 MG (Trifluridine and Tipircil) Tablets
Introduction of Trifluxen 15 mg +6.14 mg Trifluxen, encompassing 15 mg of Trifluridine and 6.14 mg of Tipiracil and produced by Everest Pharmaceutical Ltd., introduces a significant breakthrough in the field of oncology therapeutics. It offers a beacon of hope for patients grappling with specific cancer types, heralding a new era of improved outcomes and […]
Ventoxen 10 MG (Venetoclax) Tablets
Introduction: In the realm of modern oncology, Ventoxen 10 mg, imbued with the active compound Venetoclax, emerges as a landmark achievement by Everest Pharmaceutical Ltd., heralding a new dawn in cancer treatment. This medicine is specifically engineered for patients contending with hematological malignancies, illuminating a path of hope and innovation. Onco Solution, by bridging global […]
Alkixen 250 mg (Crizotinib) Capsules
Introduction: Alkixen 250 mg, containing Crizotinib and manufactured by Everest Pharmaceuticals Ltd., stands at the forefront of cancer treatment innovation. This medication represents a paradigm shift in the management of certain types of cancer, offering new hope and improved outcomes for patients worldwide. Description and Usage: Alkixen 250 mg is formulated with Crizotinib, a potent […]
Alpesib 150 MG (Alpelisib) Tablets
Introduction of Alpesib 150 mg: Alpesib 150 mg, infused with Alpelisib and developed by Everest Pharmaceuticals Ltd., marks a transformative advancement in precision oncology. This innovative medication provides targeted therapy for patients with specific genetic mutations, revolutionizing the treatment landscape and offering improved outcomes for individuals battling advanced malignancies. Description and Usage: Alpesib 150 mg […]
Ascimib 40 mg (Asciminib) Tablets
Introduction to Ascimib 40 mg (Asciminib): Abeclib 150 mg, featuring Abemaciclib and produced by Eskayef Pharmaceuticals Ltd., emerges as an innovative therapy in oncology. This medication ushers in a new era of cancer treatment, offering hope and enhanced outcomes for patients afflicted with various cancer types. Description and Usage Abeclib 150 mg incorporates abemaciclib, a […]
Enasinib 50 mg (Enasidenib) Tablets
Introduction: Enasinib 50 represents a groundbreaking advancement in cancer therapy, specifically tailored for patients with hematologic malignancies. Manufactured by Everest Pharmaceutical Ltd., this medication embodies the pinnacle of precision medicine, offering targeted treatment for individuals with IDH2 mutations. Supported by Onco Solution, a global leader in oncology medicine supply and information dissemination, Enasinib 50 mg […]
Diacer Plus 750 MG+50 MG (Diacerein+ Glucosamine Sulphate) Tablets
Introduction of Diacer Plus 750 mg+50 mg In the evolving realm of healthcare, Diacer Plus emerges as a beacon of hope for individuals grappling with the complexities of joint health. Developed by Beacon Pharmaceuticals Ltd. and globally distributed by Onco Solution, Diacer marries the therapeutic prowess of Diacerein and Glucosamine Sulphate, setting new benchmarks in […]
Selcaxen 40 MG (Selpercatinib) Tablets
Introduction: In the intricate landscape of oncology, Selcaxen 40 mg emerges as a beacon of hope, crafted with precision by Everest Pharmaceutical Ltd. and globally distributed by Onco Solution. This comprehensive exploration seeks to unravel the complexities of Selcaxen 40 mg, shedding light on its mechanisms, applications, and the collaborative synergy between Everest Pharmaceutical Ltd. […]
Selinex 20 mg (Selinexor) Tablets
Introduction: In the relentless battle against cancer, Selinex 20 mg emerges as a formidable contender, meticulously designed and manufactured by the renowned Everest Pharmaceutical Ltd. Its global availability is facilitated by the eminent Onco Solution, a key player in medicine supply and information dissemination. This comprehensive exploration aims to delve even deeper into the intricacies […]
Tofaxen 5 MG (Tofacitinib) Tablets
Tofaxen 5 MG: A Vanguard of Precision Oncology At the heart of Tofaxen 5 Mg’s groundbreaking approach is Tofacitinib, a potent Janus kinase (JAK) inhibitor. This critical component disrupts vital signaling pathways that cancer cells rely on for survival and proliferation. By targeting these pathways, Tofaxen 5 introduces a new frontier in cancer treatment, offering […]
Tucaxen 150 mg (Tucatinib) Tablets
Understanding the Mechanism and Therapeutic Application of Tucaxen 150 MG Central to Tucaxen 150 mg is its active component, Tucatinib, a potent selective HER2 inhibitor that signals a paradigm shift in cancer therapy. Tucatinib’s precision-targeted mechanism of action disrupts the aberrant signaling pathways pivotal for cancer cell growth and proliferation. This strategic approach elevates Tucaxen […]
Niranib 100 mg (Niraparib) Capsules
Introduction: In the dynamic realm of oncology, where each advancement marks a stride towards more effective and personalized treatments, Niranib 100 mg emerges as a beacon of hope. Manufactured by Everest Pharmaceutical Ltd. and globally supplied by Onco Solution, this medication encapsulates the essence of precision medicine, specifically designed to navigate the complexities of certain […]
Olanib 50 MG (Olaparib) Capsules
Introduction: In the ever-evolving landscape of oncology, Olanib 50 mg emerges as a groundbreaking intervention, manufactured with precision by Everest Pharmaceutical Ltd. and distributed globally by Onco Solution. This medication is not merely a treatment; it represents a paradigm shift in the way we approach cancer care. In this comprehensive exploration, we delve into the […]
